FIRST FOUNDATION ADVISORS
EndowmentPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1086763
Irvine, CA
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$257,802
+$25,602 QoQ
Shares Held
519
-0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,294
of 1,735 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST FOUNDATION ADVISORS holds $2,160,846 across 2 Biotechnology names. VRTX ranks #2 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,052 | $1,903,044 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
519 | $257,802 |
All Filings in VRTX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,802 | 519 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $232,200 | 520 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $233,480 | 515 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $201,694 | 515 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $229,278 | 515 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $162,645 | 347 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $155,081 | 371 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $150,955 | 371 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $296,274 | 852 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $338,185 | 961 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $268,124 | 851 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $243,152 | 842 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||